Wilmington Savings Fund Society, FSB
Position in MDCX — Medicus Pharma Ltd.
CIK 900974
WILMINGTON, DE
Position in MDCX
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$11,427
-$12,093 QoQ
Shares Held
25,622
-50.0% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 23 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MDCX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Wilmington Savings Fund Society, FSB holds $202,731,943 across 16 Drug Manufacturers - General names. MDCX ranks #16 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
348,943 | $88,621,053 | |
| 2 | LLY |
ELI LILLY & Co
|
27,892 | $33,454,503 | |
| 3 | MRK |
Merck & Co., Inc.
|
223,656 | $28,739,795 | |
| 4 | AMGN |
Amgen Inc
|
47,244 | $17,107,996 | |
| 5 | ABBV |
AbbVie Inc.
|
51,835 | $13,043,758 | |
| 6 | AZN |
Astrazeneca PLC
|
32,878 | $6,234,325 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
106,605 | $6,142,579 | |
| 8 | PFE |
Pfizer Inc
|
185,530 | $4,467,561 |
All Filings in MDCX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,427 | 25,622 | Shares | Defined | 2026-07-28 | |
| 2026-03-31 | $23,520 | 51,244 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $78,403 | 51,244 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $59,314 | 25,622 | Shares | Defined | 2025-11-20 | |
| No filing history on record for this holder in this stock. | ||||||